As STAT3 signaling is implicated in CXCR5 expression [41], STAT3 phosphorylation (pSTAT3) levels were first compared between CD4+ T-cells from untreated CLL patients, CLL patients receiving therapy at the time of analysis, and healthy donors. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.